LDLR and cancer: Although functionalization of B4C nanoparticles with anti-EGFR antibodies was not as effective as in the case of anti-LDLR, the results provide evidence that boron carbide, as a boron-rich compound, can deliver boron at very high concentrations to cancer cells.